The Clinical Significance of High Antimicrobial Resistance in Community-Acquired Urinary Tract Infections
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Clinical Significance of High Antimicrobial Resistance in Community-Acquired Urinary Tract Infections
Authors
Keywords
-
Journal
Canadian Journal of Infectious Diseases & Medical Microbiology
Volume 2020, Issue -, Pages 1-7
Publisher
Hindawi Limited
Online
2020-06-06
DOI
10.1155/2020/2967260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
- (2017) Ranita Roy et al. Virulence
- The threat of antimicrobial resistance in developing countries: causes and control strategies
- (2017) James A. Ayukekbong et al. Antimicrobial Resistance and Infection Control
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study
- (2016) Louise Rossignol et al. INFECTION
- An update on the management of urinary tract infections in the era of antimicrobial resistance
- (2016) Mazen S Bader et al. POSTGRADUATE MEDICINE
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
- (2015) F. Docobo-Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates
- (2015) Elizabeth B. Hirsch et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Urinary Tract Infections: Current and Emerging Management Strategies
- (2013) A. E. Barber et al. CLINICAL INFECTIOUS DISEASES
- Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
- (2013) Aylin Colpan et al. CLINICAL INFECTIOUS DISEASES
- Management of Urinary Tract Infections From Multidrug-Resistant Organisms
- (2013) Kalpana Gupta et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States
- (2012) Yohei Doi et al. CLINICAL INFECTIOUS DISEASES
- Carbapenemase-producingEnterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?
- (2012) Evangelia Voulgari et al. Future Microbiology
- American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
- (2012) JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
- (2011) Kalpana Gupta et al. CLINICAL INFECTIOUS DISEASES
- Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
- (2011) S. Meier et al. INFECTION
- The revival of fosfomycin
- (2011) Argyris S. Michalopoulos et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Urinary Tract Infections in Women
- (2010) Elodi J. Dielubanza et al. MEDICAL CLINICS OF NORTH AMERICA
- The epidemiology of urinary tract infection
- (2010) Betsy Foxman Nature Reviews Urology
- Antibacterial Susceptibility Testing in the Clinical Laboratory
- (2009) Thomas L. Holland et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Escherichia coli bacteriuria in female adults is associated with the development of hypertension
- (2009) Ruby Meiland et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started